IceCure Medical (ICCM) Return on Capital Employed (2021 - 2026)

IceCure Medical (ICCM) has 6 years of Return on Capital Employed data on file, last reported at 178.4% in Q1 2026.

• On a quarterly basis, Return on Capital Employed fell 5104.0% year-over-year to 178.4% in Q1 2026; TTM through Mar 2026 was 178.4%, a 5104.0% decrease from a year earlier, with the FY2025 full-year figure at 179.52%, up 471.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 178.4%, up from 156.27% in the prior quarter.
• Over the last five years, Return on Capital Employed for ICCM reached as high as 494.47% in Q2 2025 and fell as low as 160.48% in Q3 2024.
• Historically, Return on Capital Employed has averaged 34.49% across 5 years, with a median of 21.72% in 2022.
• Across the five-year window, Return on Capital Employed slumped 11129 bps in 2023 and jumped 64355 bps in 2025, its largest moves.
• Year by year, Return on Capital Employed stood at 0.39% in 2022, then sank by 28662 bps to 110.9% in 2023, then jumped by 268 bps to 186.57% in 2024, then declined by 16 bps to 156.27% in 2025, then grew by 14 bps to 178.4% in 2026.
• Per Business Quant data, the three most recent Return on Capital Employed figures were 178.4% in Q1 2026, 156.27% in Q4 2025, and 217.39% in Q3 2025.